Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NGEN.VN | FRX.TO | MSCL.TO | ||
| Company | Nervgen Pharma Corp | Fennec Pharmaceuticals Inc | Satellos Bioscience Inc | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX | TSX | ||
| Open | 4.950 | 15.32 | 11.25 | ||
| High | 5.230 | 15.32 | 11.25 | ||
| Low | 4.930 | 15.32 | 10.63 | ||
| Latest | 5.150 | 15.32 | 10.66 | ||
| Change | +0.150 | -0.10 | -0.59 | ||
| % Change | +3.00% | -0.65% | -5.24% | ||
| Volume | 66,939 | 192 | 129,743 | ||
| 20-Day Average Volume | 49,920 | 1,484 | 21,942 | ||
| Previous Close | 5.000 | 15.42 | 11.25 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | TSX Biotechnology | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.554 | 13.75 | 8.60 | ||
| 20-Day Raw Stochastic | 23.73% | 95.85% | 77.33% | ||
| 20-Day Relative Strength | 42.10 | 69.16 | 59.63 | ||
| Weighted Alpha | +39.45 | +19.83 | +31.34 | ||
| Today's Opinion | 8% Buy | 72% Buy | 24% Sell | ||
| Previous Opinion | 24% Buy | 56% Buy | 8% Buy | ||
| Last Month's Opinion | 40% Buy | 8% Buy | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.20% since 03/09/26 | +4.86% since 06/23/26 | +35.11% since 06/23/26 | ||
| Low | 4.870 on 03/13/26 | 14.49 on 06/24/26 | 7.76 on 06/24/26 | ||
| High | 5.700 on 03/10/26 | 15.48 on 06/29/26 | 11.51 on 06/29/26 | ||
| 1-Month | |||||
| %Chg | -10.28% since 02/13/26 | +12.07% since 05/29/26 | +5.54% since 05/29/26 | ||
| Low | 4.870 on 03/13/26 | 11.62 on 06/10/26 | 7.76 on 06/24/26 | ||
| High | 6.050 on 02/23/26 | 15.48 on 06/29/26 | 11.51 on 06/29/26 | ||
| 3-Month | |||||
| %Chg | -11.21% since 12/16/25 | +83.91% since 03/27/26 | +26.90% since 03/30/26 | ||
| Low | 4.870 on 03/13/26 | 7.59 on 04/13/26 | 7.67 on 04/07/26 | ||
| High | 8.490 on 01/08/26 | 15.48 on 06/29/26 | 12.94 on 04/17/26 | ||
| 6-Month | |||||
| %Chg | +38.07% since 09/16/25 | +44.53% since 12/30/25 | +34.60% since 12/30/25 | ||
| Low | 3.200 on 11/06/25 | 7.59 on 04/13/26 | 7.67 on 04/07/26 | ||
| High | 8.490 on 01/08/26 | 15.48 on 06/29/26 | 18.98 on 03/03/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 407,944 | 535,645 | 234,351 | ||
| Shares Outstanding, K | 79,213 | 34,737 | 20,831 | ||
| Annual Sales | 0 | 44,642,000 | 0 | ||
| Annual Net Income | -44,117,305 | -9,741,000 | -24,873,000 | ||
| Last Quarter Sales | 0 | 15,108,000 | 0 | ||
| Last Quarter Net Income | -1,675,549 | 201,000 | -9,768,000 | ||
| 60-Month Beta | 0.54 | 3.52 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/24/25 | 0.01 on 05/14/26 | -0.53 on 05/15/26 | ||
| Earnings Date | N/A | 08/13/26 | 03/26/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||